SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-10-012511
Filing Date
2010-03-10
Accepted
2010-03-10 16:08:49
Documents
1
Period of Report
2010-03-08

Document Format Files

Seq Description Document Type Size
1 v176796_ex.html 4  
1 v176796_ex.xml 4 3914
  Complete submission text file 0001144204-10-012511.txt   5685
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations

Mailing Address 177 POST STREET SUITE 900 SAN FRANCISCO CA 94108
Business Address
Masterson Nola E (Reporting) CIK: 0001305231 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-25169 | Film No.: 10670638